Was Jonathan Sheena’s Natera (NTRA) share sale under a Rule 10b5-1 plan?

Yes. The filing states the 6,000-share sale on August 10, 2026 was effected pursuant to a Rule 10b5-1 trading plan that Sheena adopted on December 12, 2025.

Natera co-founder sells 6,000 shares under 10b5-1 plan

Q: What did Natera (NTRA) co-founder Jonathan Sheena report in this Form 4?

Jonathan Sheena reported a sale of 6,000 shares of Natera Common Stock on August 10, 2026 under a Rule 10b5-1 plan, and updated his direct and indirect share holdings after the transaction.

Q: How many Natera (NTRA) shares did Jonathan Sheena sell and at what price?

Sheena sold 6,000 shares of Natera Common Stock at a weighted average price of $325.3237 per share. Trades occurred in multiple transactions between $325.23 and $325.46 per share, inclusive.

Q: How many Natera (NTRA) shares does Jonathan Sheena hold after this sale?

After the sale, Sheena directly held 230,464 shares of Natera Common Stock. The filing also reports 18,032 shares held indirectly for each of Caraluna 1 Trust and Caraluna 2 Trust, with beneficial ownership disclaimed.

Q: What are the Caraluna trusts mentioned in the Natera (NTRA) Form 4?

The filing reports indirect ownership of Natera shares by Caraluna 1 Trust and Caraluna 2 Trust, each holding 18,032 shares. These securities are held for the trusts’ beneficiaries, and Sheena disclaims beneficial ownership of them.

Q: Does the Natera (NTRA) Form 4 say Jonathan Sheena will provide detailed trade prices?

Yes. For the 6,000-share sale, the filing notes the reported price is a weighted average and states the holder will provide, upon written request, full information about the number of shares sold at each separate price.

Natera, Inc. director and co-founder Jonathan Sheena reported selling 6,000 shares of Common Stock on August 10, 2026 in an open-market or private transaction at a weighted average price of $325.3237 per share.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Natera, Inc. director and co-founder Jonathan Sheena reported selling 6,000 shares of Common Stock on August 10, 2026 in an open-market or private transaction at a weighted average price of $325.3237 per share. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Sheena on December 12, 2025.

Following this sale, Sheena directly held 230,464 shares of Natera common stock. Additional indirect holdings of 18,032 shares are reported for each of Caraluna 1 Trust and Caraluna 2 Trust, which are held for the benefit of the trusts’ beneficiaries; Sheena disclaims beneficial ownership of those trust-held securities.

Insider Trade Summary 10b5-1

Net Seller: 6,000 shares

Net Sell 3 txns

Insider Sheena Jonathan

Role Director

Sold 6,000 shs ($1.95M)

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F2}	6,000	$325.3237	$1.95M
holding	Common Stock ^F3	--	--	--
holding	Common Stock ^F3	--	--	--

Holdings After Transaction: Common Stock — 230,464 shares (Direct); Common Stock — 18,032 shares (Indirect, By Caraluna 1 Trust); Common Stock — 18,032 shares (Indirect, By Caraluna 2 Trust)

Footnotes (3)

F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.23 to $325.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.

Key Figures

Shares sold: 6,000 shares Weighted average sale price: $325.3237 per share Direct holdings after transaction: 230,464 shares +3 more

6 metrics

Shares sold 6,000 shares Common Stock sale on August 10, 2026 by Jonathan Sheena

Weighted average sale price $325.3237 per share Weighted average price for 6,000-share sale; trades ranged $325.23–$325.46

Direct holdings after transaction 230,464 shares Common Stock directly held by Jonathan Sheena following the reported sale

Indirect holdings per Caraluna trust 18,032 shares Common Stock reported for each of Caraluna 1 Trust and Caraluna 2 Trust; beneficial ownership disclaimed

Rule 10b5-1 plan adoption date December 12, 2025 Date Sheena adopted the trading plan used for the August 10, 2026 sale

Net shares sold 6,000 shares Net buy/sell direction across all reported non-derivative transactions in this filing

Key Terms

Rule 10b5-1 trading plan, weighted average price, beneficial ownership, indirect ownership, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The reported price in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

beneficial ownership regulatory

"The Reporting Person disclaims beneficial ownership over such securities."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

indirect ownership financial

"Indirect ownership reported as By Caraluna 1 Trust and By Caraluna 2 Trust"

open market or private transaction market

"transaction code description Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Natera (NTRA) co-founder Jonathan Sheena report in this Form 4?

Jonathan Sheena reported a sale of 6,000 shares of Natera Common Stock on August 10, 2026 under a Rule 10b5-1 plan, and updated his direct and indirect share holdings after the transaction.

How many Natera (NTRA) shares did Jonathan Sheena sell and at what price?

Sheena sold 6,000 shares of Natera Common Stock at a weighted average price of $325.3237 per share. Trades occurred in multiple transactions between $325.23 and $325.46 per share, inclusive.

How many Natera (NTRA) shares does Jonathan Sheena hold after this sale?

After the sale, Sheena directly held 230,464 shares of Natera Common Stock. The filing also reports 18,032 shares held indirectly for each of Caraluna 1 Trust and Caraluna 2 Trust, with beneficial ownership disclaimed.

What are the Caraluna trusts mentioned in the Natera (NTRA) Form 4?

The filing reports indirect ownership of Natera shares by Caraluna 1 Trust and Caraluna 2 Trust, each holding 18,032 shares. These securities are held for the trusts’ beneficiaries, and Sheena disclaims beneficial ownership of them.

Does the Natera (NTRA) Form 4 say Jonathan Sheena will provide detailed trade prices?

Yes. For the 6,000-share sale, the filing notes the reported price is a weighted average and states the holder will provide, upon written request, full information about the number of shares sold at each separate price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/14/2026 - 09:35 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sheena Jonathan

(Last)

(First)

(Middle)

C/O NATERA, INC.

13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)

AUSTIN

TEXAS

78753

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			CO-FOUNDER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/10/2026		S		6,000⁽¹⁾	D	$325.3237⁽²⁾	230,464	D
Common Stock								18,032	I	By Caraluna 1 Trust⁽³⁾
Common Stock								18,032	I	By Caraluna 2 Trust⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.23 to $325.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.

	/s/ Tami Chen, Attorney-in-Fact	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR